Matrisome Bio is an Extracellular matrix (ECM) targeting platform that leverages the properties of the ECM for the treatment of chronic diseases. We believe that our platform, which is initially focused on oncology, has the potential to change the landscape of targeted therapies across chronic diseases such as cancer, fibrosis, and cardiovascular disease.